MONDAY, April 17, 2023 (HealthDay News) — COVID-19 vaccines do not increase the risk for new-onset retinal vascular occlusion (RVO), according to a study published online April 13 in JAMA Ophthalmology.
Ian Dorney, from the Case Western Reserve University School of Medicine in Cleveland, and colleagues compared the incidence of new acute RVO diagnosis after the mRNA COVID-19 vaccine versus the influenza and tetanus, diphtheria, pertussis (Tdap) vaccines. The analysis included electronic health record data from 103 million patients.
The researchers found that of 3.1 million patients who received the mRNA COVID-19 vaccine, 104 (0.003 percent) had a new diagnosis of RVO within 21 days of vaccination. In a propensity score-matched analysis, there was no significant difference noted in the risk for new RVO diagnosis after the first dose of COVID-19 vaccination versus after the influenza (relative risk, 0.74; 95 percent confidence interval, 0.54 to 1.01) or Tdap (relative risk, 0.78; 95 percent confidence interval, 0.44 to 1.38) vaccinations. However, risk was greater after the second dose of the COVID-19 vaccination (relative risk, 2.25; 95 percent confidence interval, 1.33 to 3.81).
People are also reading…
“The findings of this study suggest that RVO diagnosed acutely after mRNA COVID-19 vaccination occurs extremely rarely at rates similar to those of two different historically used vaccinations, the influenza and Tdap vaccines,” the authors write.
Two study authors disclosed financial ties to the biotechnology and pharmaceutical industries.
Stay connected with us on social media platform for instant update click here to join our Twitter, & Facebook
We are now on Telegram. Click here to join our channel (@TechiUpdate) and stay updated with the latest Technology headlines.
For all the latest Health News Click Here
For the latest news and updates, follow us on Google News.
Denial of responsibility! NewsAzi is an automatic aggregator around the global media. All the content are available free on Internet. We have just arranged it in one platform for educational purpose only. In each content, the hyperlink to the primary source is specified. All trademarks belong to their rightful owners, all materials to their authors. If you are the owner of the content and do not want us to publish your materials on our website, please contact us by email – [email protected]. The content will be deleted within 24 hours.
